TRANSMEDICA A/S: Financial statements 2013
CVR: 17423401
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
TRANSMEDICA A/S (CVR 17423401) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 119,878,000 and a net result of DKK -139,218,000. The profit margin was -116.1%. Equity in the 2013 report amounted to DKK 66,979,000. The solvency ratio was 50.4%. The company had 80 employees in the financial year.
- Revenue
- DKK 119,878,000
- Gross Profit
- DKK 100,542,000
- Profit/Loss
- DKK -139,218,000
- Equity
- DKK 66,979,000
- Total Assets
- DKK 133,021,000
- Employees
- 80
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
TRANSMEDICA A/S has published its annual report for 2012.
As of February 1, 2013, Karsten Ramløv Svendsen has joined the board of directors of TRANSMEDICA A/S.
As of February 1, 2013, Jan Sindesen has joined the board of directors of TRANSMEDICA A/S.
As of February 1, 2013, Bernd Petersen has joined the board of directors of TRANSMEDICA A/S.
As of February 1, 2013, Erik Mølgaard has left the board of directors of TRANSMEDICA A/S.
As of February 1, 2013, Per-Håkan Persson has left the board of directors of TRANSMEDICA A/S.
As of February 1, 2013, Lars Bloch is registered as adm. dir. of TRANSMEDICA A/S.
As of February 1, 2013, Mikael Palm is registered as director of TRANSMEDICA A/S.
As of February 1, 2013, Karsten Ramløv Svendsen has stepped down as adm. dir. of TRANSMEDICA A/S.
About TRANSMEDICA A/S
TRANSMEDICA A/S is a Danish company of the type Aktieselskab based in København V, founded in 1993. The company is registered under the industry Vikarbureauers aktiviteter og anden personaleformidling. The company was previously named TRANSMEDICA ApS and GLOBAL MEDICAL SERVICE ApS. The management consists of Mikael Palm and Pia Cens. The board consists of Stig Løkke Pedersen (chair), Bo Prangsgaard and Mikael Palm. The company is owned by EVASIJU HOLDING ApS and Transmedica-Nordvik Holding ApS. The company has 56 employees (2026). In 2025, the company reported revenue of DKK 157,997,000 and a net result of DKK -18,330,000 compared with DKK -269,000 the year before. Equity in the 2025 report amounted to DKK 20,507,000.